InsiderPulse
Dashboard

EW

Edwards Lifesciences Corporation

Health CareS&P 500

Edwards Lifesciences Corporation insider trading

Edwards Lifesciences Corporation files with the SEC as a Orthopedic, Prosthetic & Surgical Appliances & Supplies company headquartered in Irvine, CA. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent EW insider transactions

7 insiders traded EW on the open market between May 11, 2026 and Sep 11, 2026 — 22 sales worth $11.2M, of which 8 were pre-scheduled under a 10b5-1 plan.

Bought
—
Sold
$11.2M

8 of 22 on a 10b5-1 plan

Net
−$11.2M
Insiders
7

Open-market purchases (code P) and sales (code S) from Edwards Lifesciences Corporation's own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 20, 2026. The live dashboard shows new filings the moment they clear.

Every EW Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

EW insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 10 insiders traded EW on the open market: 0 purchases and 83 sales worth $39.1M, 60 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 45 sales ($24.4M), by 9 insiders.

QuarterBoughtSold
Q2 2026—−$9.8M19 sales · 13 on a plan
Q1 2026—−$7M10 sales · 7 on a plan
Q4 2025—−$6.4M13 sales · 8 on a plan
Q3 2025—−$1.2M3 sales · 1 on a plan
Q2 2025—−$4.3M11 sales · 9 on a plan
Q1 2025—−$5.3M14 sales · 12 on a plan
Q4 2024—−$3.8M8 sales · 6 on a plan
Q3 2024—−$1.3M5 sales · 4 on a plan
Largest sale
−$2.8M of EW by Zovighian Bernard J (CEO · Director) on May 12, 2026, under a 10b5-1 plan.

Open-market transactions through Jun 30, 2026most recent first

  • Bobo Donald E Jr

    CVP,Strategy/Corp Development

    −$2M

    May 27, 2026

    23,145 sh · $86.42

  • Chopra Daveen

    CVP, TMTT & Surgical

    −$126.9K

    May 22, 2026

    1,500 sh · $84.60

  • Bobo Donald E Jr

    CVP,Strategy/Corp Development

    −$818.1K

    May 15, 2026

    9,968 sh · $82.07

  • Bobo Donald E Jr

    CVP,Strategy/Corp Development

    −$654.6K

    May 15, 2026

    8,000 sh · $81.82

  • Zovighian Bernard J10b5-1

    CEO · Director

    −$2.8M

    May 12, 2026

    35,506 sh · $77.92

  • Zovighian Bernard J10b5-1

    CEO · Director

    −$66.2K

    May 12, 2026

    845 sh · $78.40

  • Lippis Daniel J.10b5-1

    Cvp, Tavr

    −$85.6K

    May 04, 2026

    1,019 sh · $83.98

  • Lippis Daniel J.10b5-1

    Cvp, Tavr

    −$83K

    May 01, 2026

    1,000 sh · $82.99

  • Lippis Daniel J.10b5-1

    Cvp, Tavr

    −$1.6K

    May 01, 2026

    19 sh · $83.99

  • Ullem Scott B.10b5-1

    CVP, Chief Financial Officer

    −$664.2K

    Apr 09, 2026

    8,324 sh · $79.79

  • Ullem Scott B.10b5-1

    CVP, Chief Financial Officer

    −$376.4K

    Apr 09, 2026

    4,676 sh · $80.50

  • Lippis Daniel J.10b5-1

    Cvp, Tavr

    −$82.5K

    Apr 06, 2026

    1,019 sh · $80.98

  • Bobo Donald E Jr10b5-1

    CVP,Strategy/Corp Development

    −$1.4M

    Apr 02, 2026

    18,004 sh · $80.05

  • Bobo Donald E Jr10b5-1

    CVP,Strategy/Corp Development

    −$376.8K

    Apr 02, 2026

    4,676 sh · $80.59

  • Ullem Scott B.10b5-1

    CVP, Chief Financial Officer

    −$673.2K

    Mar 11, 2026

    7,901 sh · $85.21

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Edwards Lifesciences Corporation company record

SEC industry classification
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Headquarters
Irvine, CA
Incorporated in
DE
Listed on
NYSE
SEC Central Index Key
0001099800
Previously filed as
CVG CONTROLLED INC

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought EW

What the stock actually did in the 90 days following each open-market purchase

Don't check EW — let it ping you

Get told the moment an insider moves on EW

Pro watches Edwards Lifesciences Corporation for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add EW to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

Track EW on the live dashboardFilings on SEC.gov

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read EW insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

BAXZBHHOLXVTRSMCKCORPODDNBIXSRPTALNYBMRNINCY
This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are EW insiders buying or selling?
Between May 11, 2026 and Sep 11, 2026, 7 Edwards Lifesciences Corporation insiders made no open-market purchases and 22 sales worth $11.2M, a net sale of $11.2M. 8 of the sales were pre-scheduled under a Rule 10b5-1 plan.
How much EW stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 10 Edwards Lifesciences Corporation insiders made no open-market purchases and 83 sales worth $39.1M. 60 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 45 sales ($24.4M). The largest sale was Zovighian Bernard J selling $2.8M on May 12, 2026.
What was the largest recent EW insider trade?
Chopra Daveen (CVP, TMTT, Surgical & IHFM) sold $2.8M of EW stock on Aug 26, 2026 at about $90.99 a share.
When did an insider last buy EW shares?
No open-market purchase by a Edwards Lifesciences Corporation insider appears in the filings from May 11, 2026 to Sep 11, 2026 — every recorded open-market transaction in that period was a sale.
Where does EW insider trading data come from?
From the Form 4 filings Edwards Lifesciences Corporation's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.